DE60034865D1 - Alloferone - immunomodulierende Peptide - Google Patents

Alloferone - immunomodulierende Peptide

Info

Publication number
DE60034865D1
DE60034865D1 DE60034865T DE60034865T DE60034865D1 DE 60034865 D1 DE60034865 D1 DE 60034865D1 DE 60034865 T DE60034865 T DE 60034865T DE 60034865 T DE60034865 T DE 60034865T DE 60034865 D1 DE60034865 D1 DE 60034865D1
Authority
DE
Germany
Prior art keywords
alloferone
immunomodulating peptides
immunomodulating
peptides
antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60034865T
Other languages
English (en)
Other versions
DE60034865T2 (de
Inventor
Soo In Kim
Sergey Ivanovich Chernysh
German Petrovich Bekker
Natalia Borisovna Makhaldiani
Jules Hoffmann
Philippe Bulet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOMEDICAL LTD., MOSKAU/MOSKVA, RU
Original Assignee
Entopharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20228810&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60034865(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Entopharm Co Ltd filed Critical Entopharm Co Ltd
Publication of DE60034865D1 publication Critical patent/DE60034865D1/de
Application granted granted Critical
Publication of DE60034865T2 publication Critical patent/DE60034865T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Insects & Arthropods (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60034865T 1999-12-27 2000-12-12 Alloferone - immunomodulierende Peptide Expired - Lifetime DE60034865T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU99127725 1999-12-27
RU99127725/04A RU2172322C1 (ru) 1999-12-27 1999-12-27 Аллофероны-иммуномодулирующие пептиды

Publications (2)

Publication Number Publication Date
DE60034865D1 true DE60034865D1 (de) 2007-06-28
DE60034865T2 DE60034865T2 (de) 2007-09-06

Family

ID=20228810

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60034865T Expired - Lifetime DE60034865T2 (de) 1999-12-27 2000-12-12 Alloferone - immunomodulierende Peptide

Country Status (8)

Country Link
US (2) US6692747B2 (de)
EP (1) EP1114829B1 (de)
JP (1) JP3564065B2 (de)
KR (1) KR100394864B1 (de)
AT (1) ATE362485T1 (de)
DE (1) DE60034865T2 (de)
ES (1) ES2283269T3 (de)
RU (1) RU2172322C1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796072B1 (fr) * 1999-07-08 2003-09-19 Centre Nat Rech Scient Peptides anti-microbiens de mollusques
RU2276988C2 (ru) * 2004-01-15 2006-05-27 Сергей Иванович Черныш Антивирусное вещество
RU2267496C2 (ru) 2004-01-15 2006-01-10 Сергей Иванович Черныш Противоопухолевые и антивирусные пептиды
US7130534B1 (en) * 2005-04-21 2006-10-31 Agilent Technologies, Inc. Gas chromatograph having a radiant oven for analytical devices
EA009555B1 (ru) * 2005-11-30 2008-02-28 Сергей Иванович Черныш Пептид, обладающий иммуномодулирующей активностью, и фармацевтическая композиция
RU2338553C2 (ru) * 2006-07-13 2008-11-20 Общество с ограниченной ответственностью "Аллофарм, ООО "Аллофарм" Средство для наружного применения, обладающее противовирусной активностью
US20100150985A1 (en) * 2008-04-24 2010-06-17 George Just Dental Implant, Endodontic Instrument, and Dental Filling Material Coated with a Peptide-Based Antimicrobial and Methods of Using and Making the Same
RU2470031C2 (ru) * 2011-02-18 2012-12-20 Общество с ограниченной ответственностью "Аллоферон" Биологически активные пептидные комплексы
CN104507958B (zh) * 2012-05-21 2017-07-14 阿罗夫罗恩公司 生物活性肽复合物
KR20130138590A (ko) * 2012-06-11 2013-12-19 (주)알로텍 알로페론을 포함하는 항염증 약학적 조성물 및 화장료 조성물
KR101507101B1 (ko) 2012-07-20 2015-03-30 (주)알로텍 알로페론을 포함하는 항산화제 안정화 조성물
KR20140134957A (ko) * 2013-05-15 2014-11-25 (주)알로텍 알로페론을 포함하는 항암제 약학적 조성물
RU2560689C2 (ru) * 2013-09-06 2015-08-20 Общество с ограниченной ответственностью "Аллоферон" Способ комплексной терапии преинвазивного и инвазивного рака шейки матки
RU2014136096A (ru) * 2014-09-05 2016-03-27 Общество с ограниченной ответственностью "Аллоферон" Лекарственное средство для лечения и профилактики заболеваний верхних и нижних дыхательных путей различной этиологии, его применение и метод лечения на его основе
CN105203677A (zh) * 2015-10-16 2015-12-30 江苏大学 一种利用生物质谱技术快速检测僵蚕蛋白质的方法
RU2667128C2 (ru) * 2016-12-29 2018-09-14 Герман Петрович Беккер Композиция для приготовления противоопухолевого средства и способ приготовления противоопухолевого средства на ее основе
RU2673807C2 (ru) * 2017-05-05 2018-11-30 Общество с ограниченной ответственностью "Научно-производственная фирма "ВЕРТА" Средство, обладающее биоцидным действием
RU2737852C2 (ru) * 2017-12-28 2020-12-03 Беккер Герман Петрович Способ получения лекарственного средства на основе олигопептида аллоферона-1, имеющего противовирусную и иммуномодулирующую направленность, и лекарственное средство увеличенного срока хранения, полученное с его помощью
KR20190141607A (ko) * 2018-06-14 2019-12-24 주식회사 에이티파머 알로페론을 포함하는 췌장암 치료용 조성물 및 치료 보조제
KR102257913B1 (ko) 2018-07-17 2021-05-28 주식회사 에이티파머 알로페론을 포함하는 폐섬유증 치료용 조성물
RU2742565C1 (ru) * 2019-12-29 2021-02-08 Герман Петрович Беккер Фармацевтическая композиция, содержащая биологически активные комплексы аллоферона с цинком, и способ ее получения
KR20210106158A (ko) 2020-02-20 2021-08-30 서울대학교산학협력단 알로페론을 포함하는 항암 치료 보조제
KR20210106157A (ko) 2020-02-20 2021-08-30 서울대학교산학협력단 알로페론을 포함하는 난소암 치료용 조성물 및 치료 보조제
WO2022015194A1 (ru) * 2020-07-15 2022-01-20 Герман Петрович БЕККЕР Противовирусное средство в форме суппозитория
RU2742160C1 (ru) * 2020-09-13 2021-02-02 Общество с ограниченной ответственностью «Аллоферон» Способ лечения алеутской болезни норок
CN113234128B (zh) * 2021-05-07 2023-03-07 庶安永康(厦门)健康产业有限公司 一种抗肿瘤活性多肽及其应用
KR102626708B1 (ko) * 2022-01-28 2024-01-18 엔케이메딕스 주식회사 알로페론을 포함하는 nk세포 배양용 조성물 및 이를 이용한 nk 세포 배양방법
WO2023146008A1 (ko) * 2022-01-28 2023-08-03 엔케이메딕스 주식회사 알로페론으로 배양된 nk 세포를 함유하는 암 예방 또는 치료용 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0453849B2 (de) 1980-04-29 1992-08-27 Roosuman Urufu
ATE107317T1 (de) 1987-07-01 1994-07-15 Plant Genetic Systems Nv Bakteriozide und/oder bakteriostatische peptide, verfahren zu ihrer isolierung, herstellung und verwendung.
ATE94073T1 (de) * 1987-12-17 1993-09-15 Thomas Dr Stiefel Verwendung von haemocyaninen und arylphorinen zur beeinflussung des immmunsystems und behandlung von tumoren.
GB8911333D0 (en) 1989-05-17 1989-07-05 Plant Genetic Systems Nv New bacterial and/or bacteriostatic peptides,isolated from coleopteran insects
US5346988A (en) 1990-06-20 1994-09-13 Tampa Bay Research Institute Process for obtaining cellular protein having anti-HIV activity
CA2142007C (en) 1992-08-11 2007-10-30 Robert Glen Urban Immunomodulatory peptides
US5804558A (en) 1993-07-20 1998-09-08 University Of California Protegrins
US5482711A (en) 1993-08-25 1996-01-09 Medenica; Rajko D. Use of Nigella sativa to increase immune function
DE4334600C2 (de) 1993-10-11 1997-07-03 Hgb Pharma Service Gmbh Topische Formulierung eines solubilisierten Ginkgo-biloba-Extraktes
IT1274592B (it) 1994-08-05 1997-07-18 Angela Turiano Composizione farmaceutica per la terapia tumorale contenente xenoantigeni
AU5849796A (en) * 1994-12-27 1996-08-07 United Biomedical Inc. Peptide ratchet libraries for ctl-inducing vaccines and therapeutics
US5714577A (en) 1996-01-26 1998-02-03 University Of Pittsburgh Antimicrobial peptides
SE519350C2 (sv) 1997-01-28 2003-02-18 Anette Carlsson Antibakteriellt protein med specifik effekt mot gram-negativa bakterier, farmaceutiskt aktiva fragment därav med samma specifika effekt, samt farmaceutisk komposition innehållande proteinet eller fragment därav
CA2351161A1 (en) * 1998-11-17 2000-05-25 Curagen Corporation Nucleic acids containing single nucleotide polymorphisms and methods of use thereof

Also Published As

Publication number Publication date
US20040138137A1 (en) 2004-07-15
ATE362485T1 (de) 2007-06-15
KR100394864B1 (ko) 2003-08-19
RU2172322C1 (ru) 2001-08-20
US20020151679A1 (en) 2002-10-17
EP1114829B1 (de) 2007-05-16
ES2283269T3 (es) 2007-11-01
KR20010057591A (ko) 2001-07-04
EP1114829A3 (de) 2001-07-18
US7462360B2 (en) 2008-12-09
JP3564065B2 (ja) 2004-09-08
EP1114829A2 (de) 2001-07-11
US6692747B2 (en) 2004-02-17
DE60034865T2 (de) 2007-09-06
JP2001348399A (ja) 2001-12-18

Similar Documents

Publication Publication Date Title
DE60034865D1 (de) Alloferone - immunomodulierende Peptide
DK1025124T3 (da) Human interferon-alfa-analoge med lav toksicitet
IT1306681B1 (it) Struttura di capo traspirante da indossare per migliorare il comfortdel corpo umano.
DE69434181D1 (de) Therapeutische Peptid Derivate
CO5611160A2 (es) Conjugados de agentes terapeuticos o citotoxicos y peptidos biologicamente activos
CY1105221T1 (el) Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις
DE69734215D1 (de) Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften
BRPI0411924A (pt) métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos
ES2151467T1 (es) Inhibicion de la actividad de la quinasa p38 por aril-ureas.
HUP0102482A2 (hu) Készítmények az emberi tetű elpusztítására
CY1105008T1 (el) Αντιμικροβιακη ενεργοτητα του πρωτου κατιονικου συγκροτηματος της ανθρωπινης λακτοφερρινης
IL161319A0 (en) Use of thymulin-like peptides for making pain-relieving medicines
DE60236318D1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
ES2177625T3 (es) Citoquina cc-1 humana circulante.
IT1270618B (it) Proteine ad attivita' antitumorale
ID24060A (id) Pengolahan kulit hewan yang ditingkatkan
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DE60125232D1 (de) Kleines säurelösliches sporenprotein und seine verwendungen
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
EA200101264A1 (ru) Аллофероны-иммуномоделирующие пептиды
EA200000909A1 (ru) ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА
ATE117318T1 (de) Aus blaualgen hergestellte biologisch aktive verbindungen.
EP1303291A4 (de) Anti-hiv und anti-tumor lysozympeptide sowie fragmente
DE69813833T2 (de) 4-cyano-4-deformylsordarizin-derivate
ITRM960096V0 (it) Dispositivo per il trattamento del corpo umano.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOMEDICAL LTD., MOSKAU/MOSKVA, RU